Atlas Trials

Effect of Empagliflozin Versus Placebo on Brain Insulin Sensitivity in Patients With Prediabetes

Clinical trial NCT03227484 · COMPLETED

Trial details

NCT number
NCT03227484
Sponsor
University Hospital Tuebingen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
PreDiabetesBody Weight
Start date
2017-06-09
Primary completion
2019-10-25
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.